Joint Outcome Study

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

NCT02319070 ·Status: COMPLETED

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

NCT05621746 ·Status: RECRUITING

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Joint Health Study

NCT03358836 ·Status: COMPLETED

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

NCT00623480 ·Status: COMPLETED ·Phase: PHASE3

Clot Formation and Clot Stability in Patients With Severe Haemophilia A

NCT00279578 ·Status: COMPLETED ·Phase: NA

POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies

NCT04690322 ·Status: WITHDRAWN ·Phase: PHASE4

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

NCT04456387 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

NCT02049099 ·Status: COMPLETED

Cooperative Study of Factor VIII Inhibitors

NCT00000582 ·Status: COMPLETED ·Phase: PHASE3

Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia

NCT07099313 ·Status: RECRUITING

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)

NCT05981274 ·Status: RECRUITING

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

NCT05911763 ·Status: ACTIVE_NOT_RECRUITING

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A

NCT04845399 ·Status: COMPLETED ·Phase: PHASE3

Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901

NCT00157053 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Prophylaxis Versus on Demand Treatment for Children With Hemophilia A

NCT01810666 ·Status: COMPLETED ·Phase: PHASE4

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

NCT00178607 ·Status: COMPLETED

Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A

NCT00717626 ·Status: COMPLETED ·Phase: PHASE2

Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A

NCT01027377 ·Status: COMPLETED ·Phase: PHASE1

A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

NCT05568459 ·Status: ACTIVE_NOT_RECRUITING

A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A

NCT06297655 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A

NCT02362581 ·Status: COMPLETED ·Phase: NA